About: Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 July 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в липні 2008 (uk) مقالة علمية نشرت في 28 يوليو 2008 (ar) scientific article published on 28 July 2008 (en) գիտական հոդված հրատարակված 2008 թվականի հուլիսի 28-ին (hy)
publication date	wds:Q37233133-7BE6B9A7-5E75-46E8-B0FF-B9E24A093F59
publication date	2008-07-28 00:00:00Z (xsd:dateTime)
cites work	wds:Q37233133-AF0AFCFA-CCFE-4B92-925A-DACF669E6AA0 wds:Q37233133-C763208F-82D6-40AF-9B16-B0D0AC9A3539 wds:Q37233133-F85AAB69-AC8C-4951-AF74-A0BDF5BBE31F
cites work	An assessment of clinically useful measures of the consequences of treatment Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
author name string	wds:Q37233133-01CAE0B9-0B48-4722-A329-B14EF2C86461 wds:Q37233133-173CAE95-69C3-439E-A8F1-D311269BED07 wds:Q37233133-2045690E-D282-47D6-8638-3814A2960AC3 wds:Q37233133-2C7F0B1E-3399-4481-A4BE-B3F21750B3F4 wds:Q37233133-38FEFAED-EE47-41C2-B672-316135F18A1E wds:Q37233133-8E34BABE-6728-4C4E-84B2-2EE13C5E9798 wds:Q37233133-AFA477A3-E4DF-41EF-AD6D-344DAC06C4B2
author name string	D Patch A Corbani P Manousou C Triantos A Burroughs E Xirouchakis A Sigalas
rdfs:label	Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (en) Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (nl) Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (ast)
skos:prefLabel	Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (en) Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (nl) Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (ast)
name	Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (en) Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (nl) Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. (ast)
author	wds:Q37233133-498AEA37-5345-4A0A-AA3C-AA23C4A81844 wds:Q37233133-C80F356D-9A56-4966-A99F-0C23BB38D720
author	Gioacchino Leandro Vincenza Calvaruso
title	wds:Q37233133-62EE392D-8F98-467E-B6C8-BF18EE3DE3A8
title	Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies (en)
page(s)	wds:Q37233133-7EE84382-667C-4CCD-BA85-DDBAFD8FA720
page(s)	699-709
instance of	wds:Q37233133-5631fdfa-beaa-4271-ad6a-4407b42300f3 wds:Q37233133-7950222A-EB50-409F-A628-F2343D76B3BA wds:Q37233133-b62f3493-a4fa-4b76-8ef9-221b9c19a489
instance of	meta-analysis review article scholarly article
main subject	wds:Q37233133-4F330FFD-BFD8-431B-BA1E-2EB86053E3E3 wds:Q37233133-64CB3537-06DD-4BE4-B501-3AE728EE13E1 wds:Q37233133-7CD4770A-9B35-4536-8603-6688976A9ABE wds:Q37233133-D2E706C9-C296-418B-950A-0317CADF91B7
main subject	liver cirrhosis wd:Q421862 meta-analysis systematic review
PubMed ID	wds:Q37233133-281C19DE-2C67-4B56-BA1A-4A488159657C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18673428
PubMed ID	18673428
published in	wds:Q37233133-B339477E-D0F2-4074-BEC8-326FAD1C363F
published in	Journal of Viral Hepatitis
issue	wds:Q37233133-FCA22DB8-3851-4DB2-961E-C30606371CD7
volume	wds:Q37233133-17E8E3D2-EA55-4C09-BDF4-985A914C670B
issue	10
volume	15
DOI	wds:Q37233133-8F507BED-02AD-4F4E-B657-1EAB2C4F6C68
DOI	http://dx.doi.org/10.1111/J.1365-2893.2008.01019.X
DOI	10.1111/J.1365-2893.2008.01019.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37233133
is cites work of	Management of HCV transplant patients with triple therapy New insights in recurrent HCV infection after liver transplantation Hepatitis C virus treatment pre- and post-liver transplantation. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach. Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy The role of bridging therapy in hepatocellular carcinoma Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection New perspectives for preventing hepatitis C virus liver graft infection Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals Current management and perspectives for HCV recurrence after liver transplantation Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software